BioWorld MedTech

Jan. 8, 2014

Delphinus gains 501(k) for breast ultrasound tomography

Delphinus (Plymouth Township, Michigan) said it has received FDA 510(k) clearance for its SoftVue whole breast ultrasound tomography system, approved for diagnostic breast imaging. Read More

Sapheon continues in mission to gain FDA approval for VenaSeal

Washington Roundup: CRS analysis says med-tech tax is 'challenging to justify'

Regional Innovation Review: UT a source of innovation in Memphis medical technology

Financings roundup: Omicia closes $6.8M Series A funding round

BioWorld Survey: Let Us Know What You Think!

Deals roundup: Safeguard partner Alverix acquired by BD for $40M

Agreements/contracts: Foundation extends support of Novartis oncology program

HIT roundup: Bosch, Remedy launch new Health Buddy Web

Patent watch: USPTO accepts Tricast's first patent application

People in Places

Product briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 8, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Impact of Trump tariffs on med tech proving difficult to anticipate

BioWorld MedTech

The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...